Optimal provision of daytime NPH insulin in patients using the insulin analog lispro

Diabetes Care

Volumn 21, Issue 10, 1998, Pages 1707-1713

  Ahmed, Abu Baker E ^a   Home, Philip D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; MALE; POSTPRANDIAL PERIOD;

EID: 0031658990     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.10.1707     Document Type: Article

References (38)

1. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-985, 1993
2. Wang PH, Lau J, Chalmers TC: Meta-analysis of effects of intensive blood-glucose control on late complications on type 1 diabetes. Lancet 341:1306-1309, 1993
3. Zinman B: Insulin regimen and strategies for IDDM. Diabetes Care 16 (Suppl. 3):24-28, 1993
4. Home PD, Thow JC, Tunbridge FKE: Insulin treatment: a decade of change. Br Med Bull 45:92-110, 1989
5. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]human insulin: a rapidly absorbed analog of human regular insulin. Diabetes 43:396-402, 1994
6. Berger M, Cuppers HJ, Hegner H, Jörgens V, Berchtold P: Absorption kinetics and biologic effects of subcutaneous injected insulin preparations. Diabetes Care 5:77-91, 1982
7. Gardner DF, Arakaki RF, Podet EJ, Nell LJ, Thomas JW, Field JB: The pharmacokinetics of subcutaneous regular insulin in type 1 diabetic patients: assessment using glucose clamp technique. J Clin Endocrinol Metab 63:689-694, 1986
8. Home PD, Pickup JC, Keen H, Alberti KGMM, Parson JA, Binder C: Continuous subcutaneous insulin infusion: comparison of plasma insulin profile after infusion or bolus injection of meal-time dose. Metabolism 30:439-442, 1981
9. Brange J, Ribel U, Hansen JF, Dodson G, Hansen MT, Havelund S, Melberg SG, Norris F, Norris K, Snel L, Sorensen AR, Voigt HO: Monomeric insulin obtained by protein engineering and their medical implications. Nature 333:679-682, 1988
10. Brange J, Owen DR, Kang S, Volund A: Monomeric insulin and their experimental and clinical implications. Diabetes Care 13:923-954, 1990
11. Heinemann L, Starke AAR, Heding L, Jensen I, Berger M: Action profiles of fast onset insulin analogues. Diabetologia 33:384-386, 1990
12. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampabelli S, Brunetti P, Bolli GN: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diobetologia 37:713-720, 1994
13. ter Braak EW, Bianchi R, Erkelens DW: Faster, shorter and more profound action of [Lys(B28), Pro(B29)] human regular insulin analogue compared to regular insulin irrespective of the injection site (Abstract). Diabetes 42 (Suppl. 1):207A, 1993
14. Heinemann L, Heise T, Wahl L Ch, Trautmann ME, Starke AAR: Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(P29)] human regular insulin. Diabet Med 13:625-629, 1996
15. Burge MR, Waters DL, Holcombe JH: Prolonged efficacy of short-acting insulin lispro in combination with human Ultratard in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 82:920-924, 1997
16. Torlone E, Modarelli F, Pampanelli S, Epifano L, Lalli C, Kassi G, Del Sindaco P, Perriello G, Di Vincenzo A, Brunetti P, Rambotti AM, Bolli G: Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
17. Ahmed ABE, Home PD: The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care 21:32-37, 1998
18. Garg SK, Carmain JA, Braddy KG, Anderson JH, Vignati L, Jennings MK: Pre-meal insulin analogue lispro vs. Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
19. Anderson JH Jr, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
20. Pfützner A, Kustner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104:25-30, 1996
21. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 20:1827-1832, 1997
22. Jacobs MAJM, Keulen ETP, Kanc K, Casteleijn S, Scheffer P, Deville W, Heine RJ: Metabolic efficacy of preprandial administration of Lys(B28), Pro(29) human insulin analog in IDDM patients. Diabetes Care 20:1279-1286, 1997
23. Rowe R, Anderson JH, Gale E: A double-blind comparison of insulin lispro and regular insulin in patients on a multiple injection regimen (Abstract). Diabetes 45 (Suppl. 1):A71, 1996
24. Nielsen FS, Jörgensen LN, Ipsen M, Voldsgaard AI, Parving HH: Long-term comparison of human regular insulin analogue B10Asp and soluble human regular insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38:592-598, 1995
25. Tunbridge FKE, Home PD, Murphy M, Alberti KGMM: Does flexibility at mealtime disturb glucose control on a multiple insulin injection regimen? Diabet Med 8:833-838, 1991
26. Jörgensen LN, Nielsen FS: Timing of premeal insulins in diabetic patients on a multiple daily injection regimen: a questionnaire study (Abstract). Diabetologia 33 (Suppl. 1):A116, 1990
27. Berger M, Heinemann L: Are presently available insulin analogues clinically beneficial? (Letter) Diabet Med 40 (Suppl. 2):S91-S96, 1997
28. Heinemann L: Do insulin treated diabetic patients use an injection-meal interval in daily life? (Letter). Diabet Med 12:449-450, 1995
29. Heinemann L, Starke AAR, Hohmann A, Berger M: Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res 10 (Suppl. 26):137-139, 1992
30. Harming I, Home PD, Alberti KGMM: Measurement of free insulin concentration: the influence of the timing of extraction of insulin antibodies. Diabetologia 28:831-835, 1985
31. Soeldner JS, Slone D: Critical variables in the RIA of serum insulin using the double antibody technic. Diabetes 14:771-779, 1965
32. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Agius L, Alberti KGMM: Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate, and acetoacetate measurements in man using a centrifugal analyser with fluorimetric attachment. J Chem Clin Biochem 26:141-146, 1988
33. Burge MR, Castillo KR, Schade DS: Meal composition is a determinant of lispro-induced hypoglycemia in IDDM. Diabetes Care 20:152-155, 1997
34. Ahmed ABE, Mallias J, Home PD: Optimization of evening insulin dose in patients using the short-acting insulin analog lispro. Diabetes Care 21:1162-1166, 1998
35. Patrick AW, Collier A, Matthews DM, Macintyre CCA, Clarke BF: The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control: a comparison between human and porcine insulin. Diabet Med 5:32-35, 1988
36. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1985
37. Lean MEJ, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 290:105-108, 1985
38. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T: Insulin lispro in CSII: results of a double blind study Diabetes 46:440-443, 1997